March 11, 2005 Malcolm Stewart Vice President, DNA Medicines Avecia Limited Hexagon House, Blackley Manchester M9 8ZS EnglandCorgentech Inc • November 15th, 2005 • Pharmaceutical preparations
This letter will amend the Agreement dated December 27, 2004 between Corgentech Inc. (“Corgentech”) and Avecia Limited (“Avecia”) as previously amended by the letter from Jack X. Regan to Kevin Cox dated March 4, 2005 (as amended, the “Agreement”). Except as expressly set forth in this letter, all other terms of the Agreement shall remain unmodified and in full force and effect.
March 4, 2005 Kevin Cox Vice President, Biotechnology Avecia Limited Hexagon House, Blackley Manchester M9 8ZS EnglandCorgentech Inc • November 15th, 2005 • Pharmaceutical preparations
This letter will modify the programme of work (the “Programme”) to be carried our under Schedule 1, Part B, of the Agreement dated December 27, 2004 (the “Agreement”) between Corgentech Inc. (“Corgentech”) and Avecia Limited (“Avecia”). Except as expressly set forth in this letter, all other terms of the Agreement shall remain unmodified and in full force and effect.
